Cargando…

Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis

OBJECTIVES: In SSc, gastrointestinal tract (GIT) involvement is a major concern, with no disease-modifying and limited symptomatic therapies available. Faecal microbiota transplantation (FMT) represents a new therapeutic option for GIT-affliction in SSc, showing clinical promise in a recent controll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strahm, Noemi, Didriksen, Henriette, Fretheim, Håvard, Molberg, Øyvind, Midtvedt, Øyvind, Farstad, Inger Nina, Midtvedt, Tore, Lundin, Knut E A, Aabakken, Lars, Błyszczuk, Przemysław, Distler, Oliver, Kania, Gabriela, Hoffmann-Vold, Anna-Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393441/ https://www.ncbi.nlm.nih.gov/pubmed/36688692 http://dx.doi.org/10.1093/rheumatology/kead014

Ejemplares similares

Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
por: Fretheim, Håvard, et al.
Publicado: (2020)

Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
por: Didriksen, Henriette, et al.
Publicado: (2022)

Serum markers of cardiac complications in a systemic sclerosis cohort
por: Tennøe, Anders H., et al.
Publicado: (2022)

Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
por: Fretheim, Håvard, et al.
Publicado: (2020)

Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
por: Tennøe, Anders H., et al.
Publicado: (2019)

Gastrointestinal symptom severity and progression in systemic sclerosis
por: van Leeuwen, Nina M, et al.
Publicado: (2022)

Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
por: Vikse, Jens, et al.
Publicado: (2023)

Antibiotic resistance and genetically modified plants
por: Midtvedt, Tore
Publicado: (2014)

The gut: a triggering place for autism – possibilities and challenges
por: Midtvedt, Tore
Publicado: (2012)

Editorial: The gut and the brain – with focus on autism spectrum disorders
por: Midtvedt, Tore
Publicado: (2012)

Let's do it!
por: Midtvedt, Tore
Publicado: (2012)

Molecular Ecology in Health and Disease
por: Midtvedt, Tore
Publicado: (2012)

Society for Microbial Ecology, Microbial Ecology in Health and Disease, and the Future
por: Midtvedt, Tore
Publicado: (2013)

What did we learn today?
por: Midtvedt, Tore
Publicado: (2015)

Introducing the thematic cluster
por: Midtvedt, Tore
Publicado: (2015)

Concluding Remarks
por: Midtvedt, Tore
Publicado: (2015)

The food and the mood
por: Midtvedt, Tore
Publicado: (2017)

Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts
por: Volkmann, Elizabeth R, et al.
Publicado: (2017)

Successful treatment of spontaneous kidney graft decapsulation 18 years after renal transplantation: a case report
por: Myhre, Hans-Arne, et al.
Publicado: (2010)

Identification and Isolation of Cardiac Fibroblasts From the Adult Mouse Heart Using Two-Color Flow Cytometry
por: Stellato, Mara, et al.
Publicado: (2019)

Increase of Faecal Tryptic Activity Relates to Changes in the Intestinal Microbiome: Analysis of Crohn's Disease with a Multidisciplinary Platform
por: Midtvedt, Tore, et al.
Publicado: (2013)

Augmented concentrations of CX(3)CL1 are associated with interstitial lung disease in systemic sclerosis
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2018)

Determination of lower cut‐off levels of adalimumab associated with biochemical remission in Crohn's disease
por: Carlsen, Arne, et al.
Publicado: (2019)

TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study
por: Gudbrandsson, Birgir, et al.
Publicado: (2017)

Faecal short-chain fatty acid pattern in childhood coeliac disease is normalised after more than one year's gluten-free diet
por: Tjellström, Bo, et al.
Publicado: (2013)

Epigenomic programing: a future way to health?
por: Shenderov, Boris A., et al.
Publicado: (2014)

Factors affecting infant gut microbiota and possible consequences for health
por: Eggesbø, Merete, et al.
Publicado: (2015)

ISOLATED FECAL MICROORGANISMS CAPABLE OF 7 α-DEHYDROXYLATING BILE ACIDS
por: Gustafsson, Bengt E., et al.
Publicado: (1966)

The AP-1 Transcription Factor Fosl-2 Regulates Autophagy in Cardiac Fibroblasts during Myocardial Fibrogenesis
por: Seidenberg, Jemima, et al.
Publicado: (2021)

Probiotic lactic acid bacteria – the fledgling cuckoos of the gut?
por: Berstad, Arnold, et al.
Publicado: (2016)

Editorial: Cutting Edge Methodologies in Experimental Cardiovascular Research
por: Błyszczuk, Przemysław, et al.
Publicado: (2020)

The Molecular Basis for Oat Intolerance in Patients with Celiac Disease
por: Arentz-Hansen, Helene, et al.
Publicado: (2004)

Microplankton life histories revealed by holographic microscopy and deep learning
por: Bachimanchi, Harshith, et al.
Publicado: (2022)

Intestinal fermentation in patients with self-reported food hypersensitivity: painful, but protective?
por: Valeur, Jørgen, et al.
Publicado: (2010)

Manipulating the gut microbiota to maintain health and treat disease
por: Scott, Karen P., et al.
Publicado: (2015)

An Inverse Relative Age Effect in Male Alpine Skiers at the Absolute Top Level
por: Bjerke, Øyvind, et al.
Publicado: (2017)

Modulation of faecal metagenome in Crohn’s disease: Role of microRNAs as biomarkers
por: Rojas-Feria, María, et al.
Publicado: (2018)

Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate
por: Pollmann, Sylvie, et al.
Publicado: (2011)

Feasibility of telerehabilitation for heart failure patients inaccessible for outpatient rehabilitation
por: Lundgren, Kari Margrethe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hetsg3p7b6mcqdvjlejm8s6dra